Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Research Progress on SMARCA4 Mutation Non-small Cell Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Sept 2024

Peng Lishan, Zhong Wenzhao

Abstract excerpt

Non-small cell lung cancer (NSCLC) is one of the most prevalent and deadliest cancers worldwide. While the use of targeted therapies and immunotherapies in precision medicine has improved outcomes for some patients, a significant portion of individuals still fail to benefit, emphasizing the need to investigate the underlying mechanisms of resistance. Survival analyses have shown that NSCLC patients with SMARCA4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to DNA Helicases
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Nuclear Proteins

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 39492586
DOI: 10.3779/j.issn.1009-3419.2024.102.32
PMCID: PMC11534552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Research Progress on SMARCA4 Mutation Non-small Cell Lung Cancer].PMID 39492586Read ↗

SMARCA4: Current status and future perspectives in non-small-cell lung cancerSemantic proximity Read ↗

A Critical Review of the Impact of SMARCA4 Mutations on Survival Outcomes in Non-Small Cell Lung CancerSemantic proximity Read ↗

Clinicopathological characteristics and therapeutic outcomes in patients with non-small cell lung cancer harboring SMARCA4 mutations.Semantic proximity Read ↗

The role of SMARCA4 in lung cancerSemantic proximity Read ↗

Clinical characteristics and association with immunotherapy outcomes in SMARCA4-deficient NSCLCSemantic proximity Read ↗

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.Semantic proximity Read ↗

SMARCA4 alterations in non-small cell lung cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Clinical features and prognostic biomarkers of patients with the rare SMACRA4 gene mutation in non-small cell lung cancerSemantic proximity Read ↗

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers.Semantic proximity Read ↗

[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].Semantic proximity Read ↗

Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancerSemantic proximity Read ↗

<i>SMARCA4</i> Mutations in <i>KRAS</i>-mutant Lung Adenocarcinoma: A Multi-cohort AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.